Home Newsfeeds Bernstein Maintains Outperform on Analog Devices, Raises Price Target to $200

Bernstein Maintains Outperform on Analog Devices, Raises Price Target to $200

Bernstein analyst Stacy Rasgon maintains Analog Devices (NASDAQ:ADI) with a Outperform and raises the price target from $190 to $200.

byBenzinga Newsdesk

November 23, 2022

1 minute read

Bernstein analyst Stacy Rasgon maintains Analog Devices (NASDAQ:ADI) with a Outperform and raises the price target from $190 to $200.

Tesla To Electrify Seoul Mobility Show With Model S, Model X — Offers Limited Test Drive Tickets

By Anan Ashraf

March 24, 1:40 AM

Tesla Inc‘s (NASDAQ:TSLA) Model S and Model X will make their debut in South Korea at the 2023…

TSLA

What’s Going On With Eterna Therapeutics Stock Today?

By Adam Eckert

December 7, 11:45 AM

Eterna Therapeutics Inc (NASDAQ: ERNA) shares initially surged Wednesday morning on recent insider buying, but the stock pulled back shortly after the market open.

ERNA

Abercrombie & Fitch Sees Q1 2023 Net Sales $813M Vs $795.74M Est

By Benzinga Newsdesk

March 1, 8:43 AM

Fiscal 2023 First Quarter Outlook For the first quarter of fiscal 2023, the company expects: Net sales to be around flat to fiscal first quarter 2022 level

ANF

Nasdaq Jumps Over 200 Points; US Job Openings Tumble In July

By Lisa Levin

August 29, 12:03 PM

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 200 points on Tuesday. The Dow traded up 0.57% to 34,758.68 while the NASDAQ rose 1.61% to 13,925.71. The S&P 500, also rose, gaining, 1.13% to 4,483.44.

AXLA

Bernstein Maintains Outperform on Analog Devices, Raises Price Target to $200

Related Posts

Tesla To Electrify Seoul Mobility Show With Model S, Model X — Offers Limited Test Drive Tickets

What’s Going On With Eterna Therapeutics Stock Today?

Abercrombie & Fitch Sees Q1 2023 Net Sales $813M Vs $795.74M Est

Nasdaq Jumps Over 200 Points; US Job Openings Tumble In July